Advances in Na super(+)/I super(-) symporter (NIS) research in the thyroid and beyond

The Na super(+)/I super(-) symporter (NIS) is a plasma membrane glycoprotein that mediates active iodide uptake in the thyroid--the essential first step in thyroid hormone biosynthesis--and in other tissues, such as salivary and lactating mammary glands. Thyroidal radioiodide uptake has been used fo...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular endocrinology 2003-12, Vol.213 (1), p.59-70
Main Authors: Dohan, O, Carrasco, N
Format: Article
Language:English
Subjects:
Freshwater
Xenopus laevis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Na super(+)/I super(-) symporter (NIS) is a plasma membrane glycoprotein that mediates active iodide uptake in the thyroid--the essential first step in thyroid hormone biosynthesis--and in other tissues, such as salivary and lactating mammary glands. Thyroidal radioiodide uptake has been used for over 60 years in the diagnosis and effective treatment of thyroid cancer and other diseases. However, the NIS cDNA was only isolated in 1996 by expression cloning in Xenopus laevis oocytes, marking the beginning of the molecular characterization of NIS and the study of its regulation, both in the thyroid and other tissues. One of the most exciting current areas of NIS research-- radioiodide treatment of extrathyroidal cancers--was launched by the discovery of functional expression of endogenous NIS in breast cancer and by the ectopic transfer of the NIS gene into otherwise non NIS-expressing cancers. This review summarizes the main findings in NIS research, emphasizing the most recent developments.
ISSN:0303-7207
DOI:10.1016/j.mce.2003.10.059